Abdulkader Rahmo
President & CSO SMSbiotech
Dr. Rahmo earned his degree in Biochemistry from the Swiss Federal Institute of Technology in Zurich in 1988, before completing his PhD at the University of Southern California in Los Angeles in 1994. He subsequently undertook postdoctoral research at a major clinical laboratory in Munich, Germany.
In 1995, Dr. Rahmo established and supervised a large private clinical laboratory in Damascus specializing in molecular and genetic diagnostics. In 2001, he joined the Faculty of Medicine at the University of Damascus, where he founded the Laboratory for Genetic Research. He later co-founded the National Commission for Biotechnology in 2004, serving as Head of the Medical Biotechnology Section.
Throughout his academic career, Dr. Rahmo taught molecular biology and medical genetics at the International University for Science and Technology, as well as molecular epidemiology at the Ecole Doctorale of the Lebanese University. After moving to the United States in 2013, he served as a Visiting Scientist at Western University of Health Sciences.
Today, Dr. Rahmo is focused on advancing biotechnology through his work in stem cell innovation. His research and development efforts are centered on two key areas: regenerative medicine and the development and production of biopharmaceuticals.
Seminars
- Accelerating clinical impact through mucus clearance exploring strategies to target mucus obstruction as a reversible driver of airflow limitation, enabling faster demonstration of clinical benefit compared with interventions aimed at reversing structural lung damage
- Leveraging cell therapy for lung regeneration, utilizing nebulized cell-based interventions to modulate gene activity, reconstruct extracellular matrix, and restore lung tissue integrity
- Develop mechanistic biomarkers and integrate expanded access data to enhance dose selection, monitor early efficacy, and de-risk clinical trial design
